Method for preventing, treating, or ameliorating a microbial infection
A method for preventing, treating, or ameliorating a microbial infection can include administering thymoquinone or a pharmaceutical composition comprising thymoquinone to a patient in need thereof. The patient may be suffering from a microbial infection caused by gram-negative bacteria, gram-positive bacteria, or fungi. The microbial infection may be caused by gram negative bacteria. The gram-negative bacteria may include Acinetobacter baumannii. The gram-negative bacteria may include Pseudomonas aeruginosa. The microbial infection may be caused by antimicrobial sensitive Acinetobacter baumannii or antimicrobial resistant Acinetobacter baumannii..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Europäisches Patentamt - (2023) vom: 04. Apr. Zur Gesamtaufnahme - year:2023 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
AL-JENOOBI FAHAD IBRAHIM [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
Sonstige Themen: |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-04-04, Last update posted on www.tib.eu: 2023-06-22, Last updated: 2023-06-30 |
---|
Patentnummer: |
US11617726 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA017089190 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA017089190 | ||
003 | DE-627 | ||
005 | 20230630120704.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230614s2023 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA017089190 | ||
035 | |a (EPA)US11617726 | ||
035 | |a (EPA)69590774 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a AL-JENOOBI FAHAD IBRAHIM |e verfasserin |4 aut | |
245 | 1 | 0 | |a Method for preventing, treating, or ameliorating a microbial infection |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2023-04-04, Last update posted on www.tib.eu: 2023-06-22, Last updated: 2023-06-30 | ||
520 | |a A method for preventing, treating, or ameliorating a microbial infection can include administering thymoquinone or a pharmaceutical composition comprising thymoquinone to a patient in need thereof. The patient may be suffering from a microbial infection caused by gram-negative bacteria, gram-positive bacteria, or fungi. The microbial infection may be caused by gram negative bacteria. The gram-negative bacteria may include Acinetobacter baumannii. The gram-negative bacteria may include Pseudomonas aeruginosa. The microbial infection may be caused by antimicrobial sensitive Acinetobacter baumannii or antimicrobial resistant Acinetobacter baumannii. | ||
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a che | |
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a 615 | |
700 | 0 | |a ALAM MOHD AFTAB |4 aut | |
700 | 0 | |a AL-AGAMY MOHAMED HAMED |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 04. Apr. |
773 | 1 | 8 | |g year:2023 |g day:04 |g month:04 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/69590774/publication/US11617726A1?q=US11617726 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
936 | u | w | |j 2023 |b 04 |c 04 |
951 | |a AR | ||
952 | |j 2023 |b 04 |c 04 |